Press "Enter" to skip to content

Alkermes schizophrenia drug keeps weight gain side effect in check

Data from a late stage trial showed that patients on Alkermes’ drug had a mean weight gain of 4.21 percent after six months, compared with an average gain of 6.59 percent in patients receiving olanzapine, the most commonly used antipsychotic drug.

Original source:

Also Read:   Mitsui asks Daiichi to let IHH off the hook in Singh bros Fortis case